Assistance in Evaluation of In-licensing Opportunities
Chemfocus can review active pharmaceutical ingredient (API) information to assist your evaluation of drugs under consideration for licensing.
In particular, identification of potential development problems or patenting opportunities based on the extent of solid-state characterization, and the completeness of CMC data, can be determined.